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Abstract Beliefs about antiretroviral treatment (ART)
are crucial for treatment success but not well documented
in sub-Sahara African countries. We studied the frequency
of false beliefs about ART in 389 ART patients in Liv-
ingstone, Zambia. Despite intensive pre-ART counseling,
we find that more than half of the patients hold at least one
false belief about ART effectiveness, side effects, or the
consequences of ART non-retention or non-adherence.
Commonly held false beliefs—e.g., pastors can cure HIV
infection through prayer and ART can be stopped without
harmful effects while taking immune-boosting herbs—are
likely to decrease ART adherence and retention.
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Introduction
With an adult HIV prevalence of 14 % [1], Zambia is one
of the countries in sub-Saharan Africa highly affected by
the HIV epidemic. Antiretroviral treatment (ART) became
available in the public sector in Zambia in 2002; the pace
of ART scale-up accelerated rapidly in 2004 and 2005. By
December 2009, more than a quarter of a million people
were receiving ART in the country [2]. It is well docu-
mented that the success of ART depends crucially on
patient retention in care and high levels of treatment
adherence [3–6]. ART patients’ behavior, in turn, is likely
to depend in part on beliefs about treatment effectiveness,
side effects, and the consequences of non-retention and
non-adherence [7, 8]. It is thus important that ART patients
do not hold wrong beliefs about the treatment they receive.
For this reason, ART initiation in many treatment programs
in sub-Saharan Africa is preceded by several teaching
sessions about ART [9, 10]. Only two previous studies in
sub-Saharan Africa have reported beliefs about ART in
ART patients [10, 11]. These studies took place in the early
phases of ART scale-up in the respective countries (South
Africa in 2002 [10] and Togo in 2005 [11]). Several years
into the large-scale ART provision in sub-Saharan Africa,
our understanding of the beliefs ART patients hold about
their treatment is still limited.
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Here, we report for the first time findings on the fre-
quency of false beliefs about ART among ART patients
several years after the start of the public-sector ART scale
up in a sub-Saharan African country. Our study took
place in primary healthcare centers around Livingstone,
Zambia.
Methods
This study was conducted in 2009 in the Livingstone District
of Zambia, which is located at the border to Zimbabwe. The
district consists of Livingstone City and surrounding peri-
urban areas. The district has one general tertiary hospital and
13 primary healthcare centers the city. Of the 13 healthcare
centers, 11 provide ART. The interviewer team for this study
visited each of the 11 healthcare centers once on a randomly
selected day over a 2-week period.
All ART patients aged 18 and above who came to
receive ART at one of the 11 health centers during the day
of the visit by the study interviewer team were asked to
participate in face-to-face interviews. ART enrolment, the
minimum age of 18, and ability to give informed consent
were the only study inclusion criteria; we did not apply any
exclusion criteria. Of 421 ART patients who visited a
health center during one of the interview days, 403 patients
consented to study participation (i.e., non-participation was
less than 5 %). We excluded 14 (or 3 %) of the 403 study
participants from our final sample, because they had at
least one missing value for one of the variables used in the
analysis. Our final sample thus included 389 of the total of
1,578 active ART patients in the 11 healthcare centers in
the district. All patients in this sample provided informed,
written consent to participate in the study. The interview
included questions on socio-demographic variables and 10
true-or-false questions to evaluate different dimensions of
ART knowledge (on ART effectiveness and side effects,
ART retention, and ART adherence). We tested the ques-
tions used in this study by asking 25 patients and three
health workers to tell us how they understood the question
and what they would consider in answering it. We revised
the initial questionnaire based on the results of this pilot
study, replacing phrases and words that could be misun-
derstood with alternatives that the pilot study participants
indicated did not carry the risk of misunderstanding.
Data were processed and analyzed in SPSS 17.0 for
Macintosh. A multivariable logistic regression model was
used to examine conditional associations of the socio-
demographic variables (age, sex, education, electricity at
home, family support for ART treatment, and duration of
ART) with perfect knowledge (i.e., answering all ART
knowledge questions correctly).
Results
The median age of the respondents was 40 years (inter-
quartile range (IQR) 32–46), and the median months on
treatment was 23 (IQR 12–41). Of the 389 respondents,
5 % were male; 50 % had attained secondary-school level
of education or higher; 70 % were currently not working;
27 % were living in a house with electricity; and 88 %
received family support for ART treatment.
Overall, 56 % of respondents held at least one false
belief about ART (Table 1). Of all respondents, 41 % held
at least one false belief about ART effectiveness and side
effects; 17 % held at least one false belief about ART
retention; and 17 % held at least one false belief about
ART adherence. Table 2 shows the results of regressing an
indicator variable of perfect ART knowledge on age, sex,
education, electricity at home, family support of ART
taking, and duration of ART.
Discussion
While 95 % of respondents correctly replied that they were
aware that they would have to take medicine every day for
life once they began ART, 17 % of participants falsely
believed that HIV could be cured by ART. These two
beliefs seem incompatible but were jointly held by 16 % of
all respondents, suggesting fundamental misunderstandings
of the functioning of ART even after the comprehensive
ART counseling and education HIV patients receive pre-
ceding ART initiation. Another particularly worrisome
false belief is that pastors can cure HIV infection through
prayer (held by 17 % of participants), which suggests that
these patients may at some point decide to discontinue
medical treatment and seek cure through prayer. This
hypothesis is supported by anecdotes that ART health
workers and patients shared informally with members of
the interview team recounting that some patients had
stopped ART after attending prayer services promising to
cure their HIV infection.
The percentage of participants who described at least
one false belief relating to ART adherence was 17 %, a
figure that seems high given that all of the respondents had
previously participated in adherence counseling sessions
and were asked about adherence during the routine ART
clinic visits. Almost one in six respondents believed that
ART could not cause side effects. Such a false belief is
likely to lead to unnecessary health losses among ART
patients, as patients who do not realize that their treatment
may be the source of symptoms, may not report certain
symptoms to health workers, thus limiting the workers’
ability to intervene early and appropriately [12].
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While we cannot rule out that some participants mis-
understood a particular question—for instance, because
they interpreted the word ‘‘cure’’ as meaning ‘‘absence of
symptoms’’ rather than ‘‘elimination of HIV’’—it seems
unlikely that misunderstandings of question meanings were
common because, as described above, we carefully tested
the study questionnaire in a pilot study and revised the
initial questions based on the pilot results to minimize
the risk that particular words and phrases could be
misunderstood.
A prior study in South Africa [10] found that 50 % of
respondents believed that HIV can be cured by ART and
36 % believed that ART cannot cause side effects. The
participants in our study were substantially less likely to
hold these false beliefs (17 and 14 %, respectively). There
are several possible reasons for this difference. For one, all
participants in our study were on ART at the time of the
interview, while in the South African study only 30 % of
participants received ART [10]. This difference in sample
composition might explain the differential in false beliefs:
People receiving ART have first-hand experience with
the treatment, and it is likely that they have received more
ART-specific education than those not on ART. Further-
more, our study took place several years after the South
African study and it is likely that over calendar time ART
knowledge in the Southern African region has increased.
Our findings that the likelihood of perfect ART knowl-
edge improves with increasing education and the presence
of family support conform with our expectations. People
with higher levels of general education are likely to have
better access to information on ART and may have had
Table 1 Art beliefs




* Questions from a
questionnaire used previously
in South Africa [10]
Statement % (95 % CI) of patients who
agreed with the false statement
shown in the first column
Effectiveness and side effects
Pastors can cure HIV by prayer 17 % (13–21 %)
HIV can be cured by ART* 17 % (13–21 %)
If you start ART you will die soon 3 % (2–5 %)
ARVs cannot cause side-effects such as vomiting, rash, pain in legs* 14 % (11–18 %)
Patients with at least on false belief about ART effectiveness
and side effects
41 % (36–46 %)
Retention
You do not have to take ARVs for the rest of your life 6 % (4–9 %)
You can stop taking ARVs while you are taking immune-boosting herbs 10 % (7–13 %)
You can stop ART after you regain health 4 % (2–7 %)
You can stop ART without consulting health workers if you have
side effect
2 % (0–4 %)
Patients with at least one false belief about ART retention 17 % (13–21 %)
Adherence
Missing doses of ARVs does not lead to disease progression* 8 % (5–11 %)
There is no risk of ARVs becoming ineffective in future if you stop
taking ARVs
14 % (11–18 %)
Patients with at least one false belief about ART adherence 17 % (13–21 %)
At least one false belief 56 % (51–61 %)
Table 2 Multivariable logistic regression analysis of factors associ-
ated with perfect ART knowledge
Odds Ratio (95 % CI) P value
Age
C40 years 1.44 (0.94–2.20) 0.095
\40 years 1
Sex
Male 0.84 (0.52–1.37) 0.491
Female 1
Educational attainment
Secondary or higher 1.64 (1.06–2.52) 0.025
Primary or lower 1
Electricity at Home
Yes 0.58 (0.35–0.95) 0.030
No 1
Family support
Yes 2.38 (1.19–4.76) 0.014
No 1
Duration of ART
0–12 months 0.73 (0.44–1.21) 0.217
13–24 months 0.54 (0.32–0.91) 0.020
C24 months 1
ART antiretroviral treatment, CI confidence interval
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more exposure to teaching about human biology and other
areas of knowledge that are relevant to understanding the
functioning of ART. People whose families support them
in their ART treatment are likely to have more opportu-
nities to examine and improve their understanding of the
functioning of ART in discussions with others. Contrary to
our expectation, the presence of electricity at home, a
proxy for socioeconomic status, was negatively associated
with perfect ART knowledge in multivariable regression. It
is possible that this finding can be explained by a selection
effect: people of lower socioeconomic status are likely to
face higher hurdles to ART access, for instance, because
they may find it difficult to pay for transport to the
healthcare centers where ART is available. As a result,
only those in this group who are particularly knowledge-
able and motivated to receive ART may access the treat-
ment. In contrast, people of higher socioeconomic status
may access ART even if they are not very knowledgeable
and motivated to receive ART, because they do not face
substantial hurdles to access.
Our findings further suggest a u-shaped relationship
between ART duration and knowledge. Such a relationship
could be explained by interactions of several effects, such
as health workers improving their skills in explaining the
functioning of ART over time, patients increasingly seek-
ing out alternative sources of information on treating HIV
infection as they develop unpleasant side effects on ART,
and increased drop-out of patients with imperfect ART
knowledge. Future research needs to further elucidate the
determinants of ART knowledge, in order to ensure that
education and counseling of ART patients is effective and
appropriate at different stages in the course of ART. It will
also be important to understand in how far the quality and
intensity of the current education and counseling in pri-
mary healthcare centers in Zambia can be increased.
Previous studies have found that beliefs about ART
predict ART adherence [13, 14], but none of these studies
examined the effect of beliefs on adherence within sub-
Saharan Africa. Furthermore, no study has investigated the
relationship between belief about ART and retention in
HIV care. We find that a substantial proportion of patients
believe that they do not have to take antiretroviral drugs
(ARV) for the rest of their lives, and that they can stop
taking ARV while taking immune-boosting herbs, when
side effects occur, or after their health status has improved.
Such beliefs are likely to increase the risk of treatment
discontinuation. To inform decisions on how to optimally
allocate limited budgets for ensuring the long-term success
of ART in Zambia, future work should investigate how
important ART knowledge is for retention and adherence
relative to other factors, such as the transport and time
costs of accessing ART, forgetfulness, and stigma.
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